PRESS RELEASE published on 02/21/2024 at 14:15, 2 years ago Biotricity Strengthens its Foundation for Growth, Achieves Lower Cost of Sales, Expanding Margins of 73% and Increased Device Sales, for Third Quarter of Fiscal Year 2024 Biotricity Inc. reports Q3FY24 financial results showing topline growth, increased subscription revenue, improved margins, lower costs, and a stronger path to breakeven in the remote cardiac monitor sector of consumer healthcare Healthcare Biotricity Inc. Q3FY24 Financial Results Subscription Revenue Remote Cardiac Monitor
BRIEF published on 02/21/2024 at 14:15, 2 years ago Biotricity Inc. announces growth with a significant increase in subscriptions for the third quarter of the 2024 fiscal year Financial Results Revenue Growth Biotricity Inc. Remote Cardiac Monitoring Technological Subscriptions
PRESS RELEASE published on 02/19/2024 at 14:00, 2 years 1 month ago Biotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21st Biotricity Inc. to host Third Quarter FY 2024 Financial Results and Business Update Call on February 21, 2024, featuring Founder Dr. Waqaas Al-Siddiq and CFO John Ayanoglou. Event details and webcast information provided Financial Results Business Update Biotricity Inc. Investor Call Remote Health Monitoring
PRESS RELEASE published on 02/14/2024 at 14:00, 2 years 1 month ago Biotricity Advances Towards Breakeven Milestone - Set to Announce Record Margins and Operational Efficiency for Third Quarter of Fiscal Year 2024 Biotricity Inc. continues its shift to subscription-based revenue, emphasizing margin improvement and operational efficiency enhancements. Company to announce Third Quarter Fiscal 2024 Results on February 20, 2024 Operational Efficiency Biotricity Inc. Subscription-based Revenue Margin Improvement Third Quarter Fiscal 2024 Results
PRESS RELEASE published on 01/23/2024 at 14:15, 2 years 1 month ago Biotricity Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion Heartbeats Biotricity Inc. (NASDAQ:BTCY) has announced the expansion of its Cardiac AI Cloud platform, aiming to develop predictive monitoring to identify issues before they occur, supporting earlier interventions, and reducing healthcare costs. The company's goal is to build comprehensive AI models for improved diagnoses and interventions, having analyzed over 360 billion heartbeats and helped diagnose over 200,000 patients. The development of large data models is crucial for supporting the intermittent nature of cardiac issues and the noisy data arising from ambulatory monitoring, and for helping cardiologists service more patients. The company's effort in building a comprehensive Cardiac AI Cloud platform aims to make cardiac care accessible, affordable, and scalable, thus providing necessary support and assistance to healthcare professionals. For more information, visit www.biotricity.com. Biotricity Inc. Cardiac AI Cloud Platform Predictive Monitoring Healthcare Costs Comprehensive AI Models
Published on 03/20/2026 at 03:10, 7 hours 44 minutes ago Future Fuels Announces Filing of Amended and Restated Life Offering Document
Published on 03/20/2026 at 00:20, 10 hours 34 minutes ago Prospect Ridge To Host Investor Webinar With Presentation And Audience Q&A
Published on 03/20/2026 at 00:20, 10 hours 34 minutes ago Reeflex Solutions Inc. Announces Revocation of Management Cease Trade Order
Published on 03/19/2026 at 21:16, 13 hours 38 minutes ago Unusual Machines, Inc. Announces Proposed Public Offering
Published on 03/19/2026 at 14:20, 20 hours 34 minutes ago CBMJ CEO Rips Legacy Liberal Media Over Iran Coverage on The Schaftlein Report
Published on 03/20/2026 at 10:25, 29 minutes ago EQS-Adhoc: WashTec AG: Announcement of dividend proposal
Published on 03/20/2026 at 10:00, 54 minutes ago SWI Group secures €260M capital increase in relation to the expansion to North America of its AI & data center strategy
Published on 03/20/2026 at 09:46, 1 hour 8 minutes ago EQS-Adhoc: Aumann has announced its preliminary figures for 2025, proposed a dividend of €0.25 per share and expects an EBITDA margin of 6 to 8% for 2026, despite a decline in revenue to around €160 Million
Published on 03/20/2026 at 09:30, 1 hour 24 minutes ago Tourism Authority of Thailand invites global travellers to rediscover balance through 'Healing Journey Thailand' campaign.
Published on 03/19/2026 at 18:00, 16 hours 54 minutes ago Filing of the 2025 Universal Registration Document
Published on 03/19/2026 at 08:45, 1 day 2 hours ago Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 1 day 3 hours ago bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe